TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/12/24 21:55 | 1/10/24 | VERA | Vera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Commodore Capital LP | NY | T | S | -18,900 | 18.00 | 0 | -1,050 | -19 | 4,400 | I | |||||||||||||||
8/9/23 16:10 | 8/7/23 | VTGN | Vistagen Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Commodore Capital LP | NY | T | P | 17,961 | 23.15 | 0 | 776 | 97 | 1,575 | I | |||||||||||||||
6/22/23 16:10 | 6/20/23 | VERA | Vera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Commodore Capital LP | NY | T | P | 6,799 | 15.17 | 0 | 448 | 9 | 5,450 | I | |||||||||||||||
2/27/23 17:14 | 2/23/23 | ELVN | Enliven Therapeutics, Inc. | Health | Drug | Pharmaceutical Preparations | Commodore Capital LP | NY | T | P | 14 | 22.07 | 0 | 1 | 0 | 1,449 | I | ||||||||||||||||
2/23/23 16:05 | 2/21/23 | IMRA | Imara Inc. | DE | Health | Drug | Pharmaceutical Preparations | Commodore Capital LP | NY | T | P.m | 163 | 5.15 | 0 | 32 | 1 | 2,873 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |